Cyclopharm is an established Australian radiopharmaceutical company servicing the global medical community since 1986.
Cyclopharm is a company in the diagnostic imaging field specialising in lung health. We achieve this positioning through our proprietary medical device and pharmaceutical products under the name of TECHNEGASTM.
TECHNEGASTM has become the industry gold-standard in diagnostic functional lung imaging technology.
We distribute our products in 57 countries throughout the world with over 1500 nuclear medicine departments utilising TECHNEGASTM.
To date, over 4.2 million patient procedures are recorded.
The securities of Cyclopharm Limited (‘CYC’) will be placed in trading halt at the request of CYC, pending it releasing an announcement. Unless ASX decides otherwise, the securities will…